| Vaccines |
1 |
1 |
| COVID-19 Vaccine |
0 |
0.87 |
| Influenza |
0 |
0.79 |
| Hepatitis B Virus |
0 |
0.75 |
| Tdap Vaccine |
0 |
0.75 |
| Pneumonia |
0 |
0.68 |
| Patient Safety |
0 |
0.6 |
| Herpes Zoster |
0 |
0.59 |
| Biologic Therapy |
0 |
0.57 |
| Geriatrics |
0 |
0.55 |
| Influenza Vaccine |
0 |
0.53 |
| Immunization |
0 |
0.44 |
| Child |
0 |
0.33 |
| Adverse Effects |
0 |
0.22 |
| Diphtheria |
0 |
0.22 |
| Pandemic |
0 |
0.22 |
| Tetanus |
0 |
0.22 |
| Vaccines for Adult |
0 |
0.22 |
| COVID-19 |
0 |
0.17 |
| Pediatric Respiratory Infections |
0 |
0.15 |
| Acute Disseminated Encephalomyelitis |
0 |
0.11 |
| Centers for Disease Control and Prevention |
0 |
0.11 |
| Exercise |
0 |
0.11 |
| Fatigue |
0 |
0.11 |
| Herpes Zoster Vaccine |
0 |
0.11 |
| Monoclonal Antibody |
0 |
0.11 |
| Pain |
0 |
0.11 |
| Pertussis |
0 |
0.11 |
| Pneumococcal Vaccine |
0 |
0.11 |
| Respiratory Tract Infections |
0 |
0.11 |
| Salary and Compensation |
0 |
0.11 |
| Washington |
0 |
0.11 |
| Pain Management |
0 |
0.08 |